Dr. Christopher W. Fleming, MD

Dr. Fleming practices at Mercy Medical Group, a Service of Dignity Health Medical Foundation in Sacramento, California.

Dr. Fleming's NPI, 1245684158, was assigned on April 17, 2016. Dr. Fleming holds Ohio license 57.245058.

Dr. Fleming's primary practice is Mercy Medical Group, a Service of Dignity Health Medical Foundation, at 3000 Q St, Sacramento, CA 95816 in Sacramento County. The practice phone is (916) 733-3397.

Dr. Fleming's primary practice is Mercy Medical Group, a Service of Dignity Health Medical Foundation in Sacramento, California. Dr. Fleming is also affiliated with Cleveland Clinic Martin North Hospital. The medical group on file is Mercy Medical Group. Dmand AI also links Dr. Fleming to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fleming practices, 3 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Fleming's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Fleming is licensed in Ohio.

CMS data shows 1,138 Medicare services from Dr. Fleming across 15 procedure codes in 2024, for 162 Medicare patients. Medicare paid $90,315 for them.

CMS counts 162 Medicare patients who saw Dr. Fleming in 2024. The largest group is 65 to 74, with 82 patients. 75% of them have cancer, and 75% have high blood pressure. 7% are also on Medicaid. Their average risk score is 1.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Fleming's median patient age at 70, with 37% women.

In 2024, Dr. Fleming wrote 153 Medicare Part D claims for 63 patients. 99% of them were for generic drugs. CMS names the drug for 86 of them, across 2 drugs with 11 or more claims each, at $926 in total drug cost. In 2023, CMS named 68 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Fleming for performance year 2024, reported through an alternative payment model (APM). Dr. Fleming accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Fleming as offering telehealth.

CMS Open Payments shows 10 general payments to Dr. Fleming from 8 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 87% of the total. GT Medical Technologies, Inc paid the most, $180.